___

• Bebek N, Ertaş M.. Nöropatik pain. Ağrı 2007; 19:5-10
• Beydaun A, Backonja MM. Mechanistic stratification of antineuralgic agents. J Pain Symtom Manage 2003; 25:18-30.
• Boyd AS, Seger D, Vennucci S, Langley M, Abraham JL, King LE Jr. Mercury exposure and cutaneous disease. J Am Acad Dermatol . 2000; 43:81-90
• Butkovic D, Taljon S, Miholivolic N. Experience with gabapentin for nurophatic pain in adolescents: report of five cases. Paediatr Anaesth 2006; 16: 325-359.
• Chiang WK. Mercury. In: Ford MD, Delaney KA, Link LJ,Erickson T, editors. Clinical Toxicology. Philadelphia: WB. Saunders Company, 2001. pp737-743.
• Codd EE, Martinez RP, Molino L, Rogers KE, Stone DJ, Tallarida RJ. Tramadol and several anticonvulsants synergize in attenuating nevre injury-induced allodynia. Pain 2008;134:254-62.
• Dworkin RH, O’Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EJ, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Trede RD, Turk DC, Wallece MS. Pharmacologic management of neuropathic pain: Evidence-based recommendations.Pain 2007;132:237-251.
• Finnerup NM: Algoritm for neurophatic pain treatment: an evidence based proposal. Pain 2005;118:289-305.
• Karagöl U, Deda G, Kükner S, Ince E, Onal MZ. Pain relief by carbamazepine in mercury poisining. Eur J Pediatr. 1998; 157:260-261.
• Kennedy JD. Neuropathic pain: molecular complexity underlies continuing unmet medical need. J Med Chem. 2007; 50:2547-2556
• Keskinbora K, Pekel AF, Aydınlı I. Periferik nöropatik ağrının kontrolünde gabapentin ve amitriptilinin etkinliğinin karşılaştırılması. Ağrı2006;18:34-40.
• Korn-Merker E, Borusiak P, Boenigk HE. Gabapentin in child hood epilepsy: a prospective evaluation of efficacy and safety. Epilepsy Res 2000; 38:27-32.
• Lalwani K, Shoham A, Koh JL, McGraw T. Use of Oxycarbazepine to treat a pediatric patient with res,stant complex regional pain syndrome. J Pain. 2005; 6: 704-706.
• Laird MA, Gidal BE. Use of gabapentin in thr treatment of neurophatic pain. Ann Pharmacother 2000;34:802-807.
• Lauder GR, White MC. Neurophatic pain following multilevel surgery in children with cerebral palsy: a case series and rewiew. Pediatric Anesthesia 2005;15:412-420.
• Magos L, Clarkson TW. Overview of the clinical toxicity of mercury. Ann Clin Biochem. 2006;43:257-268.
• McGraw T, Stacey BR. Gabapentin for treatment of neurophatic pain in a 12-year –old girl. Clin J Pain. 1998;14:354-356.
• Olsson GL. Nurophatic Pain in children. In: McGrath PJ, Finlay GA, eds. Chronic and recurrent pain in children and adolescents. Progress in Pain Research and Management. Seattle, WA: IASP Pres, 2004:pp.75-95.
• Saroyan JM, Winfree CJ, Schechter WS, Roye D, Gold AP. Sciatic neurophaty after lower-extremity trauma: successful treatment of an uncommon pain and disability syndrome in an adolescent.. Am J Phys Med Rehabil.2007;86:597-600.
• Shih H, Gartner JC Jr. Weight loss, hypertensioni weakness, and limb pain in an 11-year-old boy. J Pediatr. 2001;138:566-9.
• Sindrup SH, Jensen TS: Pharmacological treatment of pain in polyneurophaty. Neurology 2000;55:915-920.
• Singh D, Kennedy DH. The use of gabapentin fort he treatment of postherpetik neuralgia (review). Clin Ther 2003;25:81-104.
• Tunçok Y, Kalyoncu Ni. T.C.Sağlık Bakanlığı Birinci Basamağa Yönelik Zehirlenmeler Tanı ve Tedavi Rehberleri 2007; 213-217.
• Yücel A, Çimen A: Neurophatic pai: mechanisms, diagnosis and treatment. Ağrı 2005;17:5-13.
• Wheeler DS, Vaux KK, Tam DA. Use of gabapentin in the treatment of childhood reflex sympathetic dystrophy. Pediatr Neurol 2000; 22:220-221.